+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Contract Manufacturing & Research Services Market Research Report by Service (Manufacturing and Research), End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 224 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5454990
UP TO OFF until Mar 31st 2023
The Global Pharmaceutical Contract Manufacturing & Research Services Market size was estimated at USD 197.80 billion in 2022, USD 211.14 billion in 2023, and is projected to grow at a CAGR of 6.88% to reach USD 336.87 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Pharmaceutical Contract Manufacturing & Research Services Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Pharmaceutical Contract Manufacturing & Research Services Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Pharmaceutical Contract Manufacturing & Research Services Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Pharmaceutical Contract Manufacturing & Research Services Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Pharmaceutical Contract Manufacturing & Research Services Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Service, the market is studied across Manufacturing and Research. The Manufacturing is further studied across Advanced Drug Delivery Formulations Packaging, API/Bulk Drugs, Finished Dose Formulations, and Packaging. The Finished Dose Formulations is further studied across Liquid Formulations, Semi-Solid Formulations, and Solid Formulations. The Research is further studied across Cardiology, Inflammation & Immunology, Neuroscience, Oncology, and Vaccines.
  • Based on End-User, the market is studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-Size Pharma.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Pharmaceutical Contract Manufacturing & Research Services Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Pharmaceutical Contract Manufacturing & Research Services Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Pharmaceutical Contract Manufacturing & Research Services Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Pharmaceutical Contract Manufacturing & Research Services Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Contract Manufacturing & Research Services Market, including AbbVie, Inc., Aenova Holding GmbH, Baxter International Inc., Boehringer Ingelheim GmbH, Catalent, Inc., Famar Group, Grifols S.A, IQVIA, Jubilant Life Sciences Limited, Lonza Group, Pfizer, Inc., Pharmaceutical Product Development, LLC, Recipharm AB, Valeant Pharmaceuticals International Inc., and Vetter Pharma-Fertigung GmbH & Co. KG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmaceutical Contract Manufacturing & Research Services Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Contract Manufacturing & Research Services Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Contract Manufacturing & Research Services Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Contract Manufacturing & Research Services Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Contract Manufacturing & Research Services Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Contract Manufacturing & Research Services Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Contract Manufacturing & Research Services Market?
Frequently Asked Questions about the Global Pharmaceutical Contract Manufacturing & Research Services Market

What is the estimated value of the Global Pharmaceutical Contract Manufacturing & Research Services Market?

The Global Pharmaceutical Contract Manufacturing & Research Services Market was estimated to be valued at $197.8 Billion in 2022.

What is the growth rate of the Global Pharmaceutical Contract Manufacturing & Research Services Market?

The growth rate of the Global Pharmaceutical Contract Manufacturing & Research Services Market is 6.8%, with an estimated value of $336.87 Billion by 2030.

What is the forecasted size of the Global Pharmaceutical Contract Manufacturing & Research Services Market?

The Global Pharmaceutical Contract Manufacturing & Research Services Market is estimated to be worth $336.87 Billion by 2030.

Who are the key companies in the Global Pharmaceutical Contract Manufacturing & Research Services Market?

Key companies in the Global Pharmaceutical Contract Manufacturing & Research Services Market include AbbVie, Inc., Aenova Holding GmbH, Baxter International Inc., Boehringer Ingelheim GmbH, Catalent, Inc., Famar Group, Grifols S.A, IQVIA and Lonza Group.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of CDMOs and rising investments in advanced manufacturing technologies by CDMOs
5.1.1.2. Rising investments in drug development & discovery and advanced manufacturing technologies
5.1.1.3. Growing outsourcing volume by big pharmaceutical companies
5.1.2. Restraints
5.1.2.1. Regulatory pressure on contract research organization services
5.1.3. Opportunities
5.1.3.1. Growing demand for specialized testing services
5.1.3.2. Growing demand for cell and gene therapies for targeted treatment
5.1.4. Challenges
5.1.4.1. Variable trade policies between countries
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Pharmaceutical Contract Manufacturing & Research Services Market, by Service
6.1. Introduction
6.2. Manufacturing
6.3.1. Advanced Drug Delivery Formulations Packaging
6.3.2. API/Bulk Drugs
6.3.3. Finished Dose Formulations
6.3.4.1. Liquid Formulations
6.3.4.2. Semi-Solid Formulations
6.3.4.3. Solid Formulations
6.3.4. Packaging
6.3. Research
6.4.1. Cardiology
6.4.2. Inflammation & Immunology
6.4.3. Neuroscience
6.4.4. Oncology
6.4.5. Vaccines

7. Pharmaceutical Contract Manufacturing & Research Services Market, by End-User
7.1. Introduction
7.2. Big Pharma
7.3. Generic Pharmaceutical Companies
7.4. Small & Mid-Size Pharma

8. Americas Pharmaceutical Contract Manufacturing & Research Services Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Pharmaceutical Contract Manufacturing & Research Services Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Contract Manufacturing & Research Services Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Product Portfolio Analysis, By Key Player
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. AbbVie, Inc.
12.2. Aenova Holding GmbH
12.3. Baxter International Inc.
12.4. Boehringer Ingelheim GmbH
12.5. Catalent, Inc.
12.6. Famar Group
12.7. Grifols S.A
12.8. IQVIA
12.9. Jubilant Life Sciences Limited
12.10. Lonza Group
12.11. Pfizer, Inc.
12.12. Pharmaceutical Product Development, LLC
12.13. Recipharm AB
12.14. Valeant Pharmaceuticals International Inc.
12.15. Vetter Pharma-Fertigung GmbH & Co. KG

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET DYNAMICS
FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY SERVICE, 2030
FIGURE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD BILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS PACKAGING, 2018-2030 (USD BILLION)
FIGURE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY API/BULK DRUGS, 2018-2030 (USD BILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD BILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD BILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD BILLION)
FIGURE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD BILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PACKAGING, 2018-2030 (USD BILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD BILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD BILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY INFLAMMATION & IMMUNOLOGY, 2018-2030 (USD BILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY NEUROSCIENCE, 2018-2030 (USD BILLION)
FIGURE 27. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD BILLION)
FIGURE 28. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD BILLION)
FIGURE 29. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 30. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 31. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 32. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIG PHARMA, 2018-2030 (USD BILLION)
FIGURE 33. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, 2018-2030 (USD BILLION)
FIGURE 34. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SMALL & MID-SIZE PHARMA, 2018-2030 (USD BILLION)
FIGURE 35. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 36. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 37. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 38. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 39. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 40. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 41. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 42. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 43. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 44. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 45. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 46. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 47. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 48. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 49. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 50. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 51. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 52. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 53. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 54. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 55. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 56. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 57. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 58. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 59. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 60. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 61. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 62. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 67. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 68. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 69. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 70. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 71. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 72. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 73. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 74. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 75. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 76. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 77. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 78. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 79. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 80. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 81. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 82. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 83. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 84. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 85. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 86. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 87. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 88. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 89. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 90. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, 2018-2030 (USD BILLION)
TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS PACKAGING, 2018-2030 (USD BILLION)
TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS PACKAGING, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS PACKAGING, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY API/BULK DRUGS, 2018-2030 (USD BILLION)
TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2018-2030 (USD BILLION)
TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, 2018-2030 (USD BILLION)
TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2030 (USD BILLION)
TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD BILLION)
TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD BILLION)
TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD BILLION)
TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD BILLION)
TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD BILLION)
TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD BILLION)
TABLE 27. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD BILLION)
TABLE 28. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PACKAGING, 2018-2030 (USD BILLION)
TABLE 29. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PACKAGING, BY REGION, 2018-2030 (USD BILLION)
TABLE 30. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY PACKAGING, BY REGION, 2018-2030 (USD BILLION)
TABLE 31. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, 2018-2030 (USD BILLION)
TABLE 32. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD BILLION)
TABLE 33. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD BILLION)
TABLE 34. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD BILLION)
TABLE 35. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 36. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 37. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY INFLAMMATION & IMMUNOLOGY, 2018-2030 (USD BILLION)
TABLE 38. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY INFLAMMATION & IMMUNOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 39. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY INFLAMMATION & IMMUNOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 40. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY NEUROSCIENCE, 2018-2030 (USD BILLION)
TABLE 41. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD BILLION)
TABLE 42. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD BILLION)
TABLE 43. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD BILLION)
TABLE 44. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 45. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 46. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY VACCINES, 2018-2030 (USD BILLION)
TABLE 47. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD BILLION)
TABLE 48. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD BILLION)
TABLE 49. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 50. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIG PHARMA, 2018-2030 (USD BILLION)
TABLE 51. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2030 (USD BILLION)
TABLE 52. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2030 (USD BILLION)
TABLE 53. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, 2018-2030 (USD BILLION)
TABLE 54. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 55. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 56. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SMALL & MID-SIZE PHARMA, 2018-2030 (USD BILLION)
TABLE 57. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY REGION, 2018-2030 (USD BILLION)
TABLE 58. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY REGION, 2018-2030 (USD BILLION)
TABLE 59. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 60. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 61. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 62. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 63. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 64. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 65. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 66. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 67. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 68. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 69. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 70. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 71. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 72. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 73. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 74. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 75. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 76. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 77. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 78. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 79. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 80. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 81. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 82. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 83. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 84. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 85. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 86. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 87. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 88. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 89. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 90. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 91. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 92. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 93. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 94. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 95. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 96. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 97. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 98. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 99. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 100. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 101. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 102. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 103. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 104. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 105. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 106. SINGAPORE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 107. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 108. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 109. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 110. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 111. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 112. TAIWAN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 113. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 114. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 115. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 116. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 117. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 118. VIETNAM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 123. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 124. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 125. DENMARK PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 126. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 127. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 128. EGYPT PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 129. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 130. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 131. FINLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 132. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 133. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 134. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 135. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 136. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 137. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 138. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 139. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 140. ISRAEL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 141. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 142. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 143. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 144. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 145. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 146. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 147. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 148. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 149. NIGERIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 150. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 151. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 152. NORWAY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 153. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 154. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 155. POLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 156. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 157. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 158. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 159. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 160. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 161. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 162. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 163. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 164. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 165. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 166. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 167. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 168. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 169. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 170. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 171. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 172. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 173. SWEDEN PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 174. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 175. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 176. SWITZERLAND PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 177. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 178. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 179. TURKEY PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 180. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 181. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 182. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 183. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 184. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD BILLION)
TABLE 185. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 186. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 187. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 188. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 189. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET RANKING, BY KEY PLAYER, 2022
TABLE 190. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 191. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 192. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET MERGER & ACQUISITION
TABLE 193. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 194. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 195. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET INVESTMENT & FUNDING
TABLE 196. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 197. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH SERVICES MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie, Inc.
  • Aenova Holding GmbH
  • Baxter International Inc.
  • Boehringer Ingelheim GmbH
  • Catalent, Inc.
  • Famar Group
  • Grifols S.A
  • IQVIA
  • Jubilant Life Sciences Limited
  • Lonza Group
  • Pfizer, Inc.
  • Pharmaceutical Product Development, LLC
  • Recipharm AB
  • Valeant Pharmaceuticals International Inc.
  • Vetter Pharma-Fertigung GmbH & Co. KG

Methodology

Loading
LOADING...